feed,title,long_url,short_url
BioRxiv,Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes,https://biorxiv.org/cgi/content/short/2021.12.11.472202v1?rss=1,https://j.mp/3oTndH0
BioRxiv,Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting,https://biorxiv.org/cgi/content/short/2021.12.12.472252v1?rss=1,https://j.mp/3s4vda8
BioRxiv,SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-Î² signaling,https://biorxiv.org/cgi/content/short/2021.12.10.472112v1?rss=1,https://j.mp/3dQqRuW
BioRxiv,SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern,https://biorxiv.org/cgi/content/short/2021.12.10.472134v1?rss=1,https://j.mp/3IPg566
BioRxiv,Mutations in RBD of SARS-CoV-2 Omicron variant result stronger binding to human ACE2 protein,https://biorxiv.org/cgi/content/short/2021.12.10.472102v1?rss=1,https://j.mp/3GWPanx
BioRxiv,Quantification of nuclear transport inhibition by SARS-CoV-2 ORF6 using a broadly applicable live-cell dose-response pipeline,https://biorxiv.org/cgi/content/short/2021.12.10.472151v1?rss=1,https://j.mp/31Pk6XU
